Classical Hematologist and Clinical InvestigatorDivision of Hematology, Massachusetts General Hospital, Harvard Medical SchoolBoston, Massachusetts, United States
PB0716 - VAYHIT: A clinical trial program evaluating the efficacy and safety of the anti-B-cell-activating factor receptor (BAFF-R)/B-cell-depleting monoclonal antibody ianalumab in patients with primary ITP
Monday, June 24, 202413:45 – 14:45 ICT
